Can-Fite BioPharma (CANF) Income from Continuing Operations (2012 - 2023)
Can-Fite BioPharma's Income from Continuing Operations was $122,000 in FY2025, down 51.2% from $250,000 in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Income from Continuing Operations (2012 - 2023) Analysis & Trends
From FY2009 onward, Can-Fite BioPharma has reported Income from Continuing Operations for 16 years.
- The FY2025 figure marks the lowest annual Income from Continuing Operations since FY2022.
- Per Business Quant data, Income from Continuing Operations in earlier years was $250,000 in FY2024 (-55.4%), $561,000 in FY2023, -$10.17 million in FY2022 and -$12.63 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Can-Fite BioPharma | 1.36 Mn | -18.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1.83 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | -1.78 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Dec 31, 2022 | -1.18 Mn |
| Sep 30, 2022 | -2.57 Mn |
| Jun 30, 2022 | -2.07 Mn |
| Mar 31, 2022 | -2.37 Mn |
| Dec 31, 2021 | -4.03 Mn |
| Sep 30, 2021 | -3.51 Mn |
| Jun 30, 2021 | -3.13 Mn |
| Mar 31, 2021 | -2.17 Mn |
| Dec 31, 2020 | -3.55 Mn |
| Sep 30, 2020 | -2.48 Mn |
| Jun 30, 2020 | -3.83 Mn |
| Dec 31, 2019 | -2.77 Mn |
| Sep 30, 2019 | -1.93 Mn |
| Jun 30, 2019 | -6.47 Mn |
| Mar 31, 2019 | 1.57 Mn |
| Dec 31, 2018 | -4.28 Mn |
API Access
Can-Fite BioPharma Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();